top of page
Researcher

ENACT-REACT COVID (microbiome signatures)

Start Date:

March 2020

End Date:

March 2022

Duration:

24 months

ID-CARE Role:
Website:

Leader

Description

Title: Study of gut microbiome signatures in COVID-19.


Design: Longitudinal laboratory-based prospective study.


Primary Objective: to assess changes in the gut microbiome composition over time according to disease severity and treatment.


Secondary Objective: to find markers of microbiome composition correlated to immunological markers of infections; to assess changes in microbiome according to coinfections.

Partners
University of Verona
Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications

Microorganisms

9/1/24

Gut Microbiome Disruption Following SARS-CoV-2: A Review

ID-CARE Participants

Evelina Tacconelli

Director

Elda Righi

Associate Professor

From our Blog
In the News
bottom of page